HEADER TRANSFERASE 22-DEC-20 7BDO TITLE MAPK14 BOUND WITH SR302 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 14,CRK1,MITOGEN-ACTIVATED PROTEIN KINASE P38 ALPHA,MAP COMPND 5 KINASE P38 ALPHA; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: MAPK14, CRK1, CSBP1, CSBP2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS P38A, INHIBITOR, MAPK14, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS KEYWDS 2 CONSORTIUM, SGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHROEDER,S.ROEHM,A.JOERGER,S.KNAPP,STRUCTURAL GENOMICS CONSORTIUM AUTHOR 2 (SGC) REVDAT 3 31-JAN-24 7BDO 1 REMARK REVDAT 2 14-SEP-22 7BDO 1 JRNL REVDAT 1 03-MAR-21 7BDO 0 JRNL AUTH S.ROHM,B.T.BERGER,M.SCHRODER,D.CHATTERJEE,S.MATHEA, JRNL AUTH 2 A.C.JOERGER,D.M.PINKAS,J.C.BUFTON,A.TJADEN,L.KOVOORU, JRNL AUTH 3 M.KUDOLO,C.POHL,A.N.BULLOCK,S.MULLER,S.LAUFER,S.KNAPP JRNL TITL DEVELOPMENT OF A SELECTIVE DUAL DISCOIDIN DOMAIN RECEPTOR JRNL TITL 2 (DDR)/P38 KINASE CHEMICAL PROBE. JRNL REF J.MED.CHEM. V. 64 13451 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34506142 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00868 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.62 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 9739 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 526 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 714 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE SET COUNT : 36 REMARK 3 BIN FREE R VALUE : 0.3130 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2605 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.42000 REMARK 3 B22 (A**2) : -0.71000 REMARK 3 B33 (A**2) : -1.72000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.422 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.316 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 28.178 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.886 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.831 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2735 ; 0.005 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2550 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3725 ; 1.352 ; 1.634 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5854 ; 1.112 ; 1.603 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 332 ; 6.906 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 139 ;31.458 ;22.374 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 435 ;15.488 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;17.757 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 359 ; 0.049 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3180 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 632 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 5 A 108 REMARK 3 ORIGIN FOR THE GROUP (A): 4.0450 32.3480 20.9990 REMARK 3 T TENSOR REMARK 3 T11: 0.1601 T22: 0.2498 REMARK 3 T33: 0.1074 T12: -0.0101 REMARK 3 T13: -0.0571 T23: -0.0500 REMARK 3 L TENSOR REMARK 3 L11: 3.1458 L22: 1.7748 REMARK 3 L33: 2.3098 L12: -2.2609 REMARK 3 L13: -1.3245 L23: 0.6556 REMARK 3 S TENSOR REMARK 3 S11: 0.1765 S12: 0.2103 S13: 0.0921 REMARK 3 S21: -0.2201 S22: -0.1465 S23: 0.0175 REMARK 3 S31: -0.1944 S32: -0.3289 S33: -0.0299 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 109 A 236 REMARK 3 ORIGIN FOR THE GROUP (A): 30.5510 35.2110 18.5050 REMARK 3 T TENSOR REMARK 3 T11: 0.0449 T22: 0.0931 REMARK 3 T33: 0.0306 T12: 0.0121 REMARK 3 T13: 0.0111 T23: -0.0176 REMARK 3 L TENSOR REMARK 3 L11: 3.1792 L22: 3.0534 REMARK 3 L33: 2.7908 L12: 1.3394 REMARK 3 L13: -0.5300 L23: -1.7521 REMARK 3 S TENSOR REMARK 3 S11: 0.1930 S12: -0.1089 S13: 0.2963 REMARK 3 S21: 0.0195 S22: -0.1372 S23: 0.1351 REMARK 3 S31: -0.1347 S32: -0.1285 S33: -0.0558 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 237 A 353 REMARK 3 ORIGIN FOR THE GROUP (A): 32.2780 27.4660 15.2580 REMARK 3 T TENSOR REMARK 3 T11: 0.1026 T22: 0.0534 REMARK 3 T33: 0.0645 T12: 0.0566 REMARK 3 T13: -0.0545 T23: -0.0113 REMARK 3 L TENSOR REMARK 3 L11: 2.3087 L22: 0.7118 REMARK 3 L33: 1.9419 L12: 0.3781 REMARK 3 L13: 0.1626 L23: -0.0686 REMARK 3 S TENSOR REMARK 3 S11: 0.0954 S12: -0.0754 S13: -0.0737 REMARK 3 S21: -0.0101 S22: -0.1030 S23: -0.1411 REMARK 3 S31: 0.1206 S32: 0.1588 S33: 0.0075 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 7BDO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1292113187. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AIMLESS 0.7.4 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11015 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 76.260 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.18100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.60100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5LAR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22,5% MMW PGSMEAR 0.1M MES, PH 6.2, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.72900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.12950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.27450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.12950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.72900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.27450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 GLU A 4 REMARK 465 SER A 32 REMARK 465 GLY A 33 REMARK 465 LYS A 118 REMARK 465 CYS A 119 REMARK 465 GLN A 120 REMARK 465 ALA A 172 REMARK 465 ARG A 173 REMARK 465 HIS A 174 REMARK 465 THR A 175 REMARK 465 ASP A 176 REMARK 465 ASP A 177 REMARK 465 GLU A 178 REMARK 465 MET A 179 REMARK 465 THR A 180 REMARK 465 GLY A 181 REMARK 465 TYR A 182 REMARK 465 VAL A 183 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 15 CG CD CE NZ REMARK 470 ILE A 17 CG1 CG2 CD1 REMARK 470 SER A 28 OG REMARK 470 HIS A 48 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 57 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 67 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 79 CG CD CE NZ REMARK 470 THR A 91 OG1 CG2 REMARK 470 ARG A 94 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 97 CG CD OE1 OE2 REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 LEU A 113 CG CD1 CD2 REMARK 470 ILE A 116 CG1 CG2 CD1 REMARK 470 VAL A 117 CG1 CG2 REMARK 470 LYS A 121 CG CD CE NZ REMARK 470 LEU A 122 CG CD1 CD2 REMARK 470 GLU A 160 CG CD OE1 OE2 REMARK 470 ASP A 161 CG OD1 OD2 REMARK 470 HIS A 199 CG ND1 CD2 CE1 NE2 REMARK 470 ILE A 259 CG1 CG2 CD1 REMARK 470 ILE A 334 CG1 CG2 CD1 REMARK 470 LEU A 353 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 14 46.44 38.60 REMARK 500 ARG A 57 74.91 21.03 REMARK 500 SER A 61 -151.89 -122.72 REMARK 500 SER A 61 -151.89 -125.04 REMARK 500 GLU A 98 31.64 -98.85 REMARK 500 HIS A 107 150.71 -48.47 REMARK 500 ILE A 116 73.66 -116.25 REMARK 500 ARG A 149 -10.30 75.66 REMARK 500 ASP A 150 35.64 -150.81 REMARK 500 ALA A 263 31.66 -94.01 REMARK 500 ASN A 278 128.13 -38.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TBK A 401 DBREF 7BDO A 1 360 UNP P47811 MK14_MOUSE 1 360 SEQADV 7BDO GLY A 0 UNP P47811 EXPRESSION TAG SEQRES 1 A 361 GLY MET SER GLN GLU ARG PRO THR PHE TYR ARG GLN GLU SEQRES 2 A 361 LEU ASN LYS THR ILE TRP GLU VAL PRO GLU ARG TYR GLN SEQRES 3 A 361 ASN LEU SER PRO VAL GLY SER GLY ALA TYR GLY SER VAL SEQRES 4 A 361 CYS ALA ALA PHE ASP THR LYS THR GLY HIS ARG VAL ALA SEQRES 5 A 361 VAL LYS LYS LEU SER ARG PRO PHE GLN SER ILE ILE HIS SEQRES 6 A 361 ALA LYS ARG THR TYR ARG GLU LEU ARG LEU LEU LYS HIS SEQRES 7 A 361 MET LYS HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL PHE SEQRES 8 A 361 THR PRO ALA ARG SER LEU GLU GLU PHE ASN ASP VAL TYR SEQRES 9 A 361 LEU VAL THR HIS LEU MET GLY ALA ASP LEU ASN ASN ILE SEQRES 10 A 361 VAL LYS CYS GLN LYS LEU THR ASP ASP HIS VAL GLN PHE SEQRES 11 A 361 LEU ILE TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SEQRES 12 A 361 SER ALA ASP ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 A 361 LEU ALA VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU ASP SEQRES 14 A 361 PHE GLY LEU ALA ARG HIS THR ASP ASP GLU MET THR GLY SEQRES 15 A 361 TYR VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET SEQRES 16 A 361 LEU ASN TRP MET HIS TYR ASN GLN THR VAL ASP ILE TRP SEQRES 17 A 361 SER VAL GLY CYS ILE MET ALA GLU LEU LEU THR GLY ARG SEQRES 18 A 361 THR LEU PHE PRO GLY THR ASP HIS ILE ASP GLN LEU LYS SEQRES 19 A 361 LEU ILE LEU ARG LEU VAL GLY THR PRO GLY ALA GLU LEU SEQRES 20 A 361 LEU LYS LYS ILE SER SER GLU SER ALA ARG ASN TYR ILE SEQRES 21 A 361 GLN SER LEU ALA GLN MET PRO LYS MET ASN PHE ALA ASN SEQRES 22 A 361 VAL PHE ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU LEU SEQRES 23 A 361 GLU LYS MET LEU VAL LEU ASP SER ASP LYS ARG ILE THR SEQRES 24 A 361 ALA ALA GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN TYR SEQRES 25 A 361 HIS ASP PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR ASP SEQRES 26 A 361 GLN SER PHE GLU SER ARG ASP LEU LEU ILE ASP GLU TRP SEQRES 27 A 361 LYS SER LEU THR TYR ASP GLU VAL ILE SER PHE VAL PRO SEQRES 28 A 361 PRO PRO LEU ASP GLN GLU GLU MET GLU SER HET TBK A 401 44 HETNAM TBK ~{N}-[[4-[[(2~{S})-4-CYCLOHEXYL-1-[[(3~{S})-1- HETNAM 2 TBK METHYLSULFONYLPIPERIDIN-3-YL]AMINO]-1-OXIDANYLIDENE- HETNAM 3 TBK BUTAN-2-YL]CARBAMOYL]PHENYL]METHYL]IMIDAZO[1,2- HETNAM 4 TBK A]PYRIDINE-3-CARBOXAMIDE FORMUL 2 TBK C32 H42 N6 O5 S FORMUL 3 HOH *94(H2 O) HELIX 1 AA1 ILE A 62 MET A 78 1 17 HELIX 2 AA2 THR A 123 ALA A 144 1 22 HELIX 3 AA3 LYS A 152 SER A 154 5 3 HELIX 4 AA4 ALA A 184 ARG A 189 5 6 HELIX 5 AA5 ALA A 190 ASN A 196 1 7 HELIX 6 AA6 THR A 203 GLY A 219 1 17 HELIX 7 AA7 ASP A 227 GLY A 240 1 14 HELIX 8 AA8 GLY A 243 LYS A 248 1 6 HELIX 9 AA9 SER A 252 LEU A 262 1 11 HELIX 10 AB1 ASN A 269 PHE A 274 1 6 HELIX 11 AB2 ASN A 278 LEU A 289 1 12 HELIX 12 AB3 THR A 298 LEU A 303 1 6 HELIX 13 AB4 ALA A 304 ALA A 309 5 6 HELIX 14 AB5 GLN A 325 ARG A 330 5 6 HELIX 15 AB6 LEU A 333 PHE A 348 1 16 SHEET 1 AA1 2 PHE A 8 LEU A 13 0 SHEET 2 AA1 2 THR A 16 PRO A 21 -1 O THR A 16 N LEU A 13 SHEET 1 AA2 5 TYR A 24 PRO A 29 0 SHEET 2 AA2 5 VAL A 38 ASP A 43 -1 O ALA A 40 N SER A 28 SHEET 3 AA2 5 HIS A 48 LYS A 54 -1 O VAL A 50 N ALA A 41 SHEET 4 AA2 5 TYR A 103 HIS A 107 -1 O THR A 106 N ALA A 51 SHEET 5 AA2 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 AA3 3 ALA A 111 ASP A 112 0 SHEET 2 AA3 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 AA3 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 SITE 1 AC1 15 TYR A 35 VAL A 38 ALA A 51 ARG A 67 SITE 2 AC1 15 GLU A 71 ILE A 84 THR A 106 HIS A 107 SITE 3 AC1 15 LEU A 108 MET A 109 ILE A 141 ILE A 166 SITE 4 AC1 15 LEU A 167 ASP A 168 PHE A 169 CRYST1 65.458 72.549 76.259 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015277 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013784 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013113 0.00000